The 20 Best Intraductal Papilloma Doctors Near Me in Ann Arbor, MI
Find the Top Intraductal Papilloma Experts and Specialists
University Of Michigan Medical Center
Alfred Chang is a General Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Chang is rated as a Distinguished provider by MediFind in the treatment of Intraductal Papilloma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Melanoma, Breast Cancer, Intraductal Papilloma, Mastectomy, and Lymphadenectomy.
Rogel Cancer Center
I ride both a road bike and Peleton. I golf about 2-3 times per week. Have four grandchildren to dote on. I mostly fiction novels. Exercise twice per week. Dr. Terebelo is rated as an Advanced provider by MediFind in the treatment of Intraductal Papilloma. He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Essential Thrombocythemia, Familial Colorectal Cancer, Bone Marrow Aspiration, and Tissue Biopsy.
University Hospital
Dr. James Hayman received his medical and master of business administration degrees simultaneously from the University of Chicago in 1991. Following an internship in Evanston, Ill., he began his radiation oncology residency at the Joint Center for Radiation Therapy at Harvard Medical School. He joined the University of Michigan faculty immediately following his residency in 1996 and currently serves as the director of the Clinical Division of the Department of Radiation Oncology. Dr. Hayman's clinical interests include the management of lung, esophageal, breast and central nervous system malignancies. He is also active in the area of health services research. Dr. Hayman is rated as an Advanced provider by MediFind in the treatment of Intraductal Papilloma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Melanoma of the Eye, Merkel Cell Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Hayman is board certified in Radiation Oncology and Hospice & Palliative Med.
Rogel Cancer Center
Dr. Jeruss is a Professor of Surgery and the Director of the University of Michigan Breast Care Center. She also holds appointments in the Departments of Pathology and Biomedical Engineering at the University of Michigan. Dr. Jeruss received her undergraduate degree in neuroscience and history from Brandeis University and her medical degree from the University of Vermont. Dr. Jeruss completed her General Surgery residency training at Northwestern University Medical School and holds a PhD from Northwestern, having done her dissertation in the field of breast cancer biology. She completed her fellowship in Breast Surgical Oncology at M.D. Anderson Cancer Center in 2006, and returned to Northwestern as Associate Professor of Surgery in the Division of Breast Surgery before joining the University of Michigan faculty.Dr. Jeruss is board certified in General Surgery and is a member of several professional societies. Through her basic and clinical research program, Dr. Jeruss has been actively involved in the training of high school students, undergraduates, graduate students at the PhD and post-doctoral levels, medical students, and residents. She has published numerous manuscripts and book chapters, and has also received many awards for teaching and research. Dr. Jeruss is rated as an Advanced provider by MediFind in the treatment of Intraductal Papilloma. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy. Dr. Jeruss is board certified in Surgery.
Rogel Cancer Center
Dr. Tasha Hughes is a Clinical Associate Professor of Surgery and a surgical oncologist at the University of Michigan. Her clinical efforts are focused on the treatment of breast cancer and melanoma. She is a health services research with a program centered around provider communication, provider bias and health care safety and quality.Dr. Hughes completed her surgical oncology training at Ohio State University Wexner Medical Center and James Comprehensive Cancer Society and her residency at Rush University Medical Center and John H. Stroger Hospital of Cook County in Chicago, IL. Dr. Hughes is rated as an Advanced provider by MediFind in the treatment of Intraductal Papilloma. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Lymphadenectomy.
Rogel Cancer Center
Dr. Lesly Dossett, MD, MPH, is the Maud T. Lane Research Professor for Cancer Quality Improvement and Chief of the Division of Surgical Oncology at the University of Michigan. Dr. Dossett earned her medical degree from Vanderbilt University School of Medicine in 2003, having attended on a United States Navy Health Professions Scholarship. She completed her general surgery residency at Vanderbilt University in 2010, which included a health services research fellowship and completion of an MPH. After residency, Dr. Dossett served on active duty with the United States Navy in several roles stateside and overseas, including completing two deployments supporting combat operations in Afghanistan. After leaving the Navy in 2014, Dr. Dossett completed a clinical fellowship in Complex General Surgical Oncology at Moffitt Cancer Center and joined the faculty of the University of Michigan in 2016.Dr. Dossett specializes in treating patients with melanoma, soft tissue sarcoma, and breast cancer. Her research leverages implementation science frameworks and behavioral strategies to improve healthcare value. As co-director of the Michigan Program for Value Enhancement (MPrOVE), she works to translate value-based research findings into practice at Michigan Medicine and then scale those strategies more broadly to hospitals and healthcare systems. She is a principal investigator for R01s funded by the National Cancer Institute (NCI) and the Agency for Healthcare Research and Quality (AHRQ). She serves as a mentor on several federally funded training grants and career development awards.Dr. Dossett is an active member of several national societies. She serves as an officer in the Association for Academic Surgeons (AAS) and in the executive leadership of the American College of Surgeons (ACS) Cancer Research Program (CRP) and the Surgical Outcomes Club.Clinical Specialization:Dr. Dossett’s clinical focus is on melanoma and non-melanoma skin cancers, sarcoma, and breast cancer. She has expertise in locally and regionally advanced melanoma, breast angiosarcoma, retroperitoneal and pelvic sarcoma, breast conservation therapy, and skin and nipple sparing mastectomy. Dr. Dossett is rated as an Advanced provider by MediFind in the treatment of Intraductal Papilloma. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Retroperitoneal Liposarcoma, Melanoma, Desmoplastic Small Round Cell Tumor, Mastectomy, and Lymphadenectomy. Dr. Dossett is board certified in Surgery and Complex General Surgical Oncology.
University Hospital
Terri Bott-Kothari, MD has been in practice for over 16 years treating all disease sites. She completed her medical training at Wayne State University School of Medicine and residency at the University of Cincinnati. Dr. Bott is rated as an Experienced provider by MediFind in the treatment of Intraductal Papilloma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Familial Prostate Cancer. Dr. Bott is board certified in Radiation Oncology.
University Hospital
Medical school: Creighton University School of Medicine; Internship: University of Michigan Hospitals- Pediatrics/Internal Medicine; Residency: University of Cleveland Hospitals- Radiation Oncology. Dr. Kane is rated as an Experienced provider by MediFind in the treatment of Intraductal Papilloma. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Metastatic Brain Tumor, and Breast Cancer. Dr. Kane is board certified in Radiation Oncology.
University Hospital
Dr. Derek Bergsma is active in clinical practice at the Lacks Cancer Center Department of Radiation Oncology in Grand Rapids. He received his undergraduate degree from Grand Valley State University and then worked in cancer immunodiagnostics at Van Andel Institute before obtaining his medical degree from Michigan State University College of Human Medicine. He completed both internship and Radiation Oncology residency at the University of Rochester in Rochester, NY. Dr. Bergsma is rated as an Experienced provider by MediFind in the treatment of Intraductal Papilloma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Brain Tumor, Astrocytoma, and Oligodendroglioma. Dr. Bergsma is board certified in Radiation Oncology.
C. S. Mott Children's Hospital
Christian J. Vercler, M.D. is a faculty member in the Section of Plastic Surgery in the Department of Surgery with a joint appointment in the Department of Neurosurgery at Michigan Medicine. He serves as Co-Chief of the Clinical Ethics Service of the Center for Bioethics and Social Sciences in Medicine at the University of Michigan. He is a diplomate of both the American Board of Surgery and the American Board of Plastic Surgery.Dr. Vercler received his Bachelor of Science in Biology and Master of Arts in Theological Studies from Wheaton College (IL). He attended medical school at the University of Illinois College of Medicine. He completed general surgery training at Emory University and plastic surgery at the Harvard Plastic Surgery Program. He then did an additional fellowship in Craniofacial Surgery at the University of Michigan.Dr. Vercler has a special interest in medical ethics. He completed a Fellowship in Clinical Ethics at the Emory University Center for Ethics and earned a Masters of Arts degree in Bioethics from Trinity. He currently serves as the Chair of the Pediatric Ethics Committee of C.S. Mott Children’s Hospital and is Co-Chair of the Adult Ethics Committee at Michigan Medicine. Additionally, he is chair of the Bioethics Committee of the Michigan State Medical Society and past chair of both the ASPS Ethics Committee and Ethics Interest Group of the American Cleft Palate-Craniofacial Association.Clinical Specialization:Dr. Vercler focuses primarily on pediatric plastic surgery and craniofacial deformities in children and adults. Dr. Vercler is rated as an Experienced provider by MediFind in the treatment of Intraductal Papilloma. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Metopic Ridge, Craniosynostosis, Plagiocephaly, Bone Graft, and Osteotomy. Dr. Vercler is board certified in Surgery and Plastic Surgery.
Taubman Center
Michael Englesbe, MD, FACS is the Cyrenus G Darling Sr M.D. and Cyrenus G Darling Jr M.D. Professor of Surgery at the University of Michigan in the Section of Transplantation Surgery. Dr. Englesbe received his undergraduate degree at Yale University in New Haven, Connecticut in 1993. He went on to obtain his medical degree in 1997 from the Robert Wood Johnson Medical School and completed his general surgery residency at the University of Michigan Health System in 2004. From 2000 to 2002, Dr. Englesbe did a surgical research post-doctoral fellowship at the University of Washington Medical Center in Seattle, Washington. He does kidney and liver transplantation in adults and children. He has a specific expertise in portal hypertension in children and adults.Education Focus:Dr. Englesbe particularly enjoys working with undergraduate students, medical students, and young physician trainees. He serves as the Department of Surgery Vice Chair for Resident Mentorship and the University of Michigan Medical School Capstone Curriculum Director.Clinical Specialization:Dr. Englesbe specializes in kidney and liver transplantation in adults and children. He has a specific expertise in portal hypertension in children and adults. Dr. Englesbe is rated as an Experienced provider by MediFind in the treatment of Intraductal Papilloma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Hernia, Liver Failure, End-Stage Renal Disease (ESRD), Liver Transplant, and Kidney Transplant. Dr. Englesbe is board certified in Surgery.
University Hospital
Steven Allen is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Allen is rated as an Experienced provider by MediFind in the treatment of Intraductal Papilloma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Lung Cancer, HER-2 Positive Breast Cancer, and Pleuropulmonary Blastoma. Dr. Allen is board certified in Radiation Oncology.
Rogel Cancer Center
Dr. Morikawa joined the faculty in August 2014. After earning her M.Mus. in Piano Performance and M.PH in Epidemiology and Biostatistics from Boston University, Dr. Morikawa received her MD/Ph.D. at the Emory University School of Medicine. After completing her internal medicine residency training at Emory, she underwent fellowship training in Medical Oncology at Memorial Sloan Kettering Cancer Center. In 2014, she joined the faculty of the University of Michigan. She specializes in the care of patients with breast cancer at the Rogel Cancer Center. Her research involves clinical and translational investigations in breast cancer as well as brain and leptomeningeal metastases from solid tumors. Dr. Morikawa is rated as an Experienced provider by MediFind in the treatment of Intraductal Papilloma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Morikawa is board certified in Internal Medicine and Medical Oncology.
Rogel Cancer Center
Dr. Angeles is an Associate Professor with Tenure of Surgery, Associate Professor of Dermatology, and Faculty Member in the Cancer Biology PhD Program at the University of Michigan in the Division of Surgical Oncology. She earned her medical degree at Tufts University School of Medicine. She completed general surgery residency at New York Presbyterian-Weill Cornell Medical Center. While in residency she completed a two-year basic/translational science Surgical Oncology Research Fellowship at Memorial Sloan-Kettering Cancer Center (MSKCC) focusing on the molecular biology and novel therapeutics for sarcoma. After residency, Dr. Angeles returned to MSKCC and completed a clinical Complex Surgical Oncology Fellowship. Dr. Angeles is board-certified in both General Surgery and Complex General Surgical Oncology. She is the Director of the Regional Cancer Therapies Clinic at University of Michigan/Rogel Cancer Center. Dr. Angeles is a nationally recognized surgeon-scientist dedicated to advancing cancer care through innovative research and compassionate patient care. As the lead investigator for multiple clinical trials at the Rogel Cancer Center, she is at the forefront of developing new treatments for melanoma and sarcoma. Her laboratory studies the immune system’s role in fighting cancer, with a special focus on how resident memory T cells can help create long-lasting protection against tumors. By combining basic science and translational research, Dr. Angeles and her team are working to transform discoveries in the lab into effective new therapies for patients. Dr. Angeles’s research has been supported by the American Cancer Society, the Melanoma Research Alliance, the Society of Surgical Oncology, and the National Institutes of Health’s National Cancer Institute (NCI-NIH).Committed to excellence in both science and patient care, Dr. Angeles is a Fellow of the American College of Surgeons, a Fellow of the Society of Surgical Oncology, and an active member of professional societies including the American Society of Clinical Oncology (ASCO), the Society of Surgical Oncology (SSO), the Connective Tissue Oncology Society (CTOS), and the Society for Immunotherapy of Cancer (SITC). She also serves as Chair of the Society of Surgical Oncology's Research Committee, helping to shape the future of cancer research and treatment.Clinical Specialization:Dr. Angeles is a board-certified surgical oncologist whose clinical practice focuses on patients with soft tissue cancers including sarcoma, melanoma, and non-melanoma cutaneous malignancies. Dr. Angeles cares for patients in a robust multidisciplinary fashion and provides education and counseling to her patients in order to allow shared decision making for the surgical management of their disease. Dr. Angeles is rated as an Experienced provider by MediFind in the treatment of Intraductal Papilloma. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Melanoma, Splenectomy, and Nephrectomy. Dr. Angeles is board certified in Surgery and Complex General Surgical Oncology.
University Hospital
Dr. Daniel Chang is a nationally and internationally recognized expert in radiotherapy for GI malignancies. His primary research interest is in advanced radiotherapy techniques, primarily with stereotactic body radiotherapy (SBRT). He has led several studies investigating and establishing the efficacy and safety for SBRT for these diseases for liver and pancreatic tumors. His other research interests include normal tissue tolerances, quality of life after radiotherapy, and combining radiotherapy with targeted agents. In addition, he has a strong interest in the use of radiotherapy, particularly in combination with systemic agents, in patients with metastatic disease. Another area of interest is in health care utilization for patients with metastatic disease and using machine learning and other approaches to optimize care during the end-of-life period.Dr. Chang is interested in developing novel modalities and technologies for delivering radiotherapy. He previously led the FDA trial that led to approval of PET-guided radiotherapy, which in broader terms, is called Biology-guided radiotherapy. In addition, he has experience with MR-guided radiotherapy, and he is interested in exploring the role of particle therapy and heave ion radiotherapy.Dr. Chang received his MD from Wayne State University in 2002 and completed his residency in Radiation Oncology at the University of Florida in Gainesville, Florida in 2007. He then joined the Department of Radiation Oncology at Stanford University from 2007-2022, having previously served as residency program director from 2012-2017 and the Vice Chair of Clinical Operations from 2017-2022 where he was also the Sue and Bob McCollum Professor in Radiation Oncology.Dr. Chang is a member of the American Society of Radiation Oncology (ASTRO), American Radium Society (ARS), and the American Society of Clinical Oncology (ASCO). He serves on the scientific committee for ASTRO, ASCO, and GI ASCO. He has authored or co-authored over 190 peer-reviewed publications for journals including Journal of Clinical Oncology, Journal of the National Cancer Institute, Clinical Cancer Research, Radiology, International Journal of Radiation Oncology, Biology, and Physics, Radiotherapy and Oncology, and Cancer. He served as the senior editor for the GI section of the International Journal of Radiation Oncology, Biology, and Physics from 2013-2017 and is currently on the editorial board for Practical Radiation Oncologysince 2020. He served on the Hepatobiliary Panel for the National Cancer Comprehensive Network (NCCN) guidelines from 2013-2022, helping to shape national guidelines for the work-up, diagnosis, and treatment of patients with hepatobiliary cancers. He is currently the track chair for the GI track for the ASTRO Annual Meeting Scientific Committee. He also serves on the Education Committee for the Gastrointestinal Cancer - Gastroesophageal, Pancreatic, and Hepatobiliary Track for the ASCO annual meeting starting in 2023. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of Intraductal Papilloma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Familial Pancreatic Cancer. Dr. Chang is board certified in Radiation Oncology.
Domino's Farms
Adeyiza O. Momoh, M.D., James W. Crudup Professor serves as a faculty member in the Section of Plastic Surgery at Michigan Medicine.Dr. Momoh received his BS in Biology from Calvin College and his M.D. degree from Northwestern University School of Medicine. He completed his plastic surgery training at the Baylor College of Medicine, Michael E. DeBakey department of surgery. Following this, he spent a year of fellowship training in microsurgical breast reconstruction and aesthetic breast surgery at the Beth Israel Deaconess Medical Center of Harvard Medical School in Boston, Massachusetts.He is a member of the American Society of Plastic Surgeons, American College of Surgeons, American Society for Reconstructive Microsurgery, Plastic Surgery Research Council, Reed O. Dingman Society, Michigan Academy of Plastic Surgeons, and American Council of Academic Surgeons.Clinical Specialization: Dr. Momoh specializes in all forms of breast reconstruction and has a particular interest in microsurgical breast reconstruction, utilizing a variety of perforator flaps such as the DIEP, SIEA and SGAP flaps. Additional areas of clinical focus include breast augmentation, breast lifts and body procedures for mothers aimed at restoration of form following pregnancy. Dr. Momoh is rated as an Experienced provider by MediFind in the treatment of Intraductal Papilloma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy. Dr. Momoh is board certified in Plastic Surgery.
Domino's Farms
Paige L. Myers, MD, MPH, FACS, serves as a faculty member in the Section of Plastic Surgery at the University of Michigan School of Medicine and is the program director of the Integrated Plastic Surgery Residency. Dr. Myers obtained a Bachelor of Science Degree in Chemistry from Hobart and William Smith College. She then attended Upstate Medical University in Syracuse, NY for her medical degree. She completed a Plastic and Reconstructive Surgery Residency at the University of Rochester. She pursued a fellowship in reconstructive microsurgery at Memorial Sloan Kettering Cancer Center in New York, NY, to provide the most advanced reconstructive techniques to her patients.Clinical Specialization: Dr. Myers specializes in all forms of breast reconstruction, with a particular focus on microsurgical techniques. She has specialized training in using patients' own tissue from the abdomen, thighs, hips, or gluteal region. Additional clinical areas include lymphedema surgery and complex oncologic reconstruction, working closely with the University of Michigan Rogel Cancer Center to provide multidisciplinary, patient-centered care. Her research interests involve investigating the social determinants of health and current policies that affect the delivery of care for breast reconstruction and lymphedema patients. She is also passionate about mentorship and sponsorship in surgery, especially for women and underrepresented minorities. Dr. Myers is rated as an Experienced provider by MediFind in the treatment of Intraductal Papilloma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Breast Enlargement In Males, Breast Cancer, Lymphedema, Mastectomy, and Lymphadenectomy. Dr. Myers is board certified in Plastic Surgery.
Domino's Farms
Jeffrey H. Kozlow, MD, serves as a Clinical Associate Professor in the Section of Plastic and Reconstructive Surgery at the University of Michigan School of Medicine. A native of Southeastern Michigan, Dr. Kozlow received his Bachelors of Arts in Psychology and Chemistry from Cornell University. He graduated from Johns Hopkins University School of Medicine for his M.D. degree. He underwent Plastic Surgery Residency training at the University of Michigan followed by an additional one-year fellowship in Microvascular Reconstructive Surgery at the University of Texas – MD Anderson Cancer Center. He has returned to the University of Michigan joining the faculty in 2011. Clinical Specialization: Dr. Kozlow is clinically focused on the reconstruction of oncologic and traumatic defects. His microsurgical training allows him to perform abdominally-based breast reconstruction including DIEP and muscle-sparing TRAM flaps. He partners with members of the University of Michigan Rogel Cancer Center to provide an integrated and multi-disciplinary reconstruction for complex defects including the extremities and pelvis. His goal is to perform reconstructions that optimize the function and form that can be lost following the surgical removal of tumors. He also treats patients with primary cutaneous malignancies including melanoma and other skin cancers. Dr. Kozlow is rated as an Experienced provider by MediFind in the treatment of Intraductal Papilloma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Eccrine Porocarcinoma, Melanoma, Breast Cancer, Mastectomy, and Lymphadenectomy. Dr. Kozlow is board certified in Plastic Surgery.
University Hospital
James Fugazzi is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Fugazzi is rated as an Experienced provider by MediFind in the treatment of Intraductal Papilloma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Familial Prostate Cancer. Dr. Fugazzi is board certified in Radiation Oncology.
University Of Michigan Medical Center
Lori Pierce is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Pierce is rated as an Experienced provider by MediFind in the treatment of Intraductal Papilloma. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Angiosarcoma, and Intraductal Papilloma.
Last Updated: 04/28/2026

















